- The trend backdrop is active with a 11-week active streak.
- Price is above Fair Value, showing premium demand versus the model.
- Next-week expectancy is positive at 58.33% based on similar historical setup states.
SRTA
NASDAQ
Week ended 31 Jul 2026
Weekly Investor Report
Strata Critical Medical, Inc. · Healthcare · Medical Care Facilities
Latest close
5.02 USD
-0.4%
latest week
Weekly setup
Mixed setup
The weekly trend is active. Price is -0.7% below the Trend Line and sits at 44.2% of its 52-week range. The latest completed week returned -0.4%, after a -7.2% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 56/100 conviction, while the latest news-sentiment score is 56/100. Near-term considerations: earnings are due in 1d.
Setup score
42
out of 100
Latest Close
5.02 USD
31 Jul 2026
1W Return
-0.4%
latest completed week
4W Return
-7.2%
short-term follow-through
12W Return
-9.9%
quarterly tape
Trend Breadth
22.4%
11 of 49 weeks active
Volume Ratio
1.0x
vs 13-week average
- Price is below the Trend Line, which keeps downside pressure in focus.
- Activity pressure is negative, which weakens the current setup.
- 2 reversal markers appear in the recent smart-money tape.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-0.4%
Latest completed week; four-week move -7.2%.
Indicator stack
50/35
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 58.33%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
Options pressure
Volatility
56/100 conviction; expected move 18.4%.
News sentiment
56/100
49 relevant articles in the latest sentiment read.
Event risk
1d
Next report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is -0.7% below the Trend Line and sits at 44.2% of its 52-week range. The latest completed week returned -0.4%, after a -7.2% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.0x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5112-week average 0.47
12-week confirmation
Trend active11/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.51Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers
No recent accumulation markers. 2 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -7.2% over four weeks, -9.9% over 12 weeks, and - over one year. The current trend has remained active for 11 consecutive weeks.
Performance by holding period
Active trend streak11 weeks
Active weeks in one year11
Trend breadth22.4%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.26Latest activity-pressure read.
Pressure change-131.1%Four-week change in activity pressure.
Leadership-Latest relative-leadership reading.
RS change-Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 26 Jul 2026
Financial statements through 31 Mar 2026
Field coverage 79%
Model confidence 76%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength37/100Blend of value, momentum, and quality. Underlying universe rank 64; rank 1 is best.
Value67/100Relative valuation strength. Underlying universe rank 34; rank 1 is best.
Quality4/100Profitability and accounting quality. Underlying universe rank 97; rank 1 is best.
Momentum36/100Medium-term price momentum. Underlying universe rank 65; rank 1 is best.
Growth27/100Revenue and earnings growth. Underlying universe rank 74; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 9.3x Price divided by trailing earnings.
- Price / sales
- 1.7x Market value relative to trailing revenue.
- EV / EBITDA
- - Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- -6.9% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 21.7% Gross profit retained from each unit of revenue.
- Operating margin
- -7.4% Operating profit retained from revenue.
- Free-cash-flow margin
- -10.3% Free cash flow generated from revenue.
- Return on invested capital
- -6.1% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 1.1% Latest one-year revenue growth.
- EPS growth
- - Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- -154.2% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 3/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- - Cash dividends relative to market value.
- Buyback yield
- -0.0% Net share repurchases relative to market value.
- Shareholder yield
- -0.0% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 5.8x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Options positioningVolatility
SRTA shows volatility options pressure with a 56/100 conviction score, put-call volume ratio of 0.00, expected move of 18.4%, and Sharemaestro trend signal active.
Conviction56/100
Expected move18.4%
Put/call volume0.00
Insider activity-
No recent insider transactions are stored for this company.
News sentiment56/100
Weighted news tone is neutral across 49 relevant articles.
13 positive · 34 neutral · 2 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings1dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
Options expected move18.4%Nearest-chain priced movement where available.
52-week drawdown-22.8%Distance below the 52-week high.
13-week volatility7.6%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
6 Mar
3 Apr
1 May
29 May
26 Jun
31 Jul
Weeks higher12 of 2614 weeks finished lower.
Best week+17.4%Week of 22 May.
Worst week-9.9%Week of 26 Jun.
Latest week-0.4%Week of 31 Jul.
Shape of recent returns
Strong gains6
Modest gains6
Flat weeks0
Modest losses7
Sharp losses7
Recent vol7.6%13-week weekly-return volatility.
Base vol8.9%52-week weekly-return volatility.
Up/down split25/22Count of positive and negative weeks in the 52-week window.
Average skew6.9% / -6.4%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorUS Healthcare
4-week rank- / 100
Group average-1.5%
Trend breadth52.0%
Trend52.0%active weekly trend signals
MD78.0%positive activity pressure
RS49.0%positive relative leadership
Four-week leaders
IndustryUS Medical Care Facilities
4-week rank30 / 44
Group average-3.0%
Trend breadth70.5%
Trend70.5%active weekly trend signals
MD84.1%positive activity pressure
RS54.5%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape46/100
Trend, activity pressure, participation, and risk combine to a 46/100 tape read.
Indicator analysis56/100Latest 12-week confirmation: trend 11/12, activity pressure 11/12, relative leadership 0/12.
Activity pressure 0.51; 2 reversal markers Next-Week ExpectancyPositive 58.33%Next-week expectancy is positive with a 58.33% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors34/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 70; Small Cap Core rank 38 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Options42/100SRTA shows volatility options pressure with a 56/100 conviction score, put-call volume ratio of 0.00, expected move of 18.4%, and Sharemaestro trend signal active.
Volatility · Volatility expansion watch · Expected move 18.4% Sentiment56/100Weighted news tone is neutral across 49 relevant articles.
Strata Critical Medical Ord Shs Class A (SRTA) Institutional Confidence Insiders50/100No recent insider transaction evidence is stored.
Earnings1dNext report is scheduled for 04 Aug 2026; event risk rises as the date approaches.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 31 Jul 2026 | 5.02 USD | -0.4% | 5.05 USD | 4.95 USD | -0.26 | - | 5.3M | On |
| 24 Jul 2026 | 5.04 USD | -2.1% | 5.05 USD | 4.95 USD | 0.05 | - | 4.8M | On |
| 17 Jul 2026 | 5.15 USD | 0.8% | 5.05 USD | 4.95 USD | 0.33 | - | 3.8M | On |
| 10 Jul 2026 | 5.11 USD | -5.5% | 5.04 USD | 4.94 USD | 0.64 | - | 5.1M | On |
| 3 Jul 2026 | 5.41 USD | 2.1% | 5.05 USD | 4.94 USD | 0.85 | - | 6.6M | On |
| 26 Jun 2026 | 5.30 USD | -9.9% | 5.01 USD | 4.93 USD | 0.87 | - | 6.4M | On |
| 19 Jun 2026 | 5.88 USD | 8.3% | 4.98 USD | 4.92 USD | 0.89 | - | 7.9M | On |
| 12 Jun 2026 | 5.43 USD | -6.2% | 4.92 USD | 4.90 USD | 0.91 | - | 6.3M | On |
| 5 Jun 2026 | 5.79 USD | -8.2% | 4.90 USD | 4.88 USD | 0.97 | - | 4.0M | On |
| 29 May 2026 | 6.31 USD | 2.9% | 4.86 USD | 4.86 USD | 1.05 | - | 3.5M | On |
| 22 May 2026 | 6.13 USD | 17.4% | 4.81 USD | 4.82 USD | 0.86 | - | 5.9M | On |
| 15 May 2026 | 5.22 USD | -6.3% | 4.78 USD | 4.79 USD | 0.52 | - | 6.2M | Off |
| 8 May 2026 | 5.57 USD | 9.6% | 4.77 USD | 4.78 USD | 0.01 | - | 6.2M | Off |
| 1 May 2026 | 5.08 USD | 3.3% | 4.74 USD | 4.76 USD | -0.54 | - | 2.5M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.